The Energy Code

Dr. Mike Belkowski
  • 4.8 (125)
  • ALTERNATIVE HEALTH
  • UPDATED WEEKLY

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

  1. 4H AGO

    Your Liver Clock Controls Your Muscle Energy (Even If You Sleep “Fine”)

    Most people think circadian rhythm is just sleep hygiene. This deep dive shows it’s metabolic infrastructure. In a hepatocyte-specific BMAL1 knockout mouse model, skeletal muscle clock genes kept oscillating — but a huge slice of muscle metabolic rhythms didn’t. Roughly 1/3 of rhythmic muscle genes were re-tuned when the liver clock was disrupted, and the biggest hit landed on mitochondrial respiration: over half of oscillatory oxidative phosphorylation genes changed. Even more compelling, serum transfer experiments showed the liver clock helps deliver a nighttime endocrine “upshift” signal that primes muscle cells for oxidative phosphorylation and ATP output. Translation: when circadian timing breaks, your organs stop cooperating and that “random fatigue” can be a timing problem, not a motivation problem. (Educational content only, not medical advice.) - Article Discussed in Episode: The liver clock tunes transcriptional rhythms in skeletal muscle to regulate mitochondrial function - Key Quotes From Dr. Mike: “The liver is not just a metabolic organ, it’s a timing organ.” “Your liver’s internal clock isn’t just running liver chemistry, it’s tuning mitochondrial function in skeletal muscle.” “About one third of rhythmic muscle genes are influenced by the liver clock.” “If your clocks are misaligned, your organs stop cooperating and the symptoms look like fatigue, cravings, and poor recovery.” “Longevity and performance aren’t only about what you do — they’re about when you do it.” - Key points Liver clock ≠ muscle clock control: muscle core clock rhythms stayed largely intact even when hepatocyte BMAL1 was deleted. But the liver clock tunes muscle metabolism: ~30.5% of rhythmic muscle genes shifted with liver clock disruption. Rhythmic gene changes split into: ~14.7% lost oscillation, ~14.1% gained oscillation, ~1.7% changed phase/amplitude. Carb metabolism rhythms were most resilient (~85.2% unaffected). Lipid metabolism rhythms were more sensitive (~26.9% affected). Mitochondrial programs were hit hardest: ~35.8% of mitochondrial envelope rhythmic genes affected. OxPhos was the headline: ~58.3% of oscillatory oxidative phosphorylation genes were affected. Active-phase serum is the signal carrier: WT night serum upregulated ribosomal + OxPhos genes in myotubes. Liver clock disruption breaks the night signal: ZT16 serum from knockout mice altered 136/210 serum-responsive genes vs WT. Functional readout matched: myotubes treated with knockout dark-phase serum showed lower ATP production(Seahorse). Practical translation: circadian alignment = organ cooperation, and “energy dips” may reflect mistimed endocrine signaling. - Episode timeline 0:19–1:40 — The thesis: circadian rhythm + liver + muscle mitochondria are one network 1:42–3:12 — Circadian basics + BMAL1 as the non-redundant clock driver 3:15–4:55 — Model: hepatocyte-specific BMAL1 knockout; muscle clock genes largely intact 5:00–6:20 — The headline: ~30.5% of rhythmic muscle genes shift with liver clock disruption 6:20–9:30 — Pathway impacts: carbs resilient; lipids sensitive; OxPhos heavily affected (~58.3%) 9:41–12:45 — Serum transfer experiments: WT night serum induces OxPhos/ribosome genes; knockout night serum breaks it 13:33–14:30 — Function test: Seahorse shows lower ATP production with knockout dark-phase serum 16:00–18:45 — What might the signal be? hepatokines, metabolites, EVs; secretion machinery may be altered 19:35–22:53 — Practical takeaways: timing as infrastructure; meal timing + morning light; energy dips as timing problem 22:53–23:15 — Close: “not just what you do — when you do it” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    24 min

  2. 1D AGO

    Does Red Light Therapy Actually Work? 3 Studies, 3 Very Different Answers

    Photobiomodulation (PBM) and low-level light therapy (LLLT) are everywhere, and so are the claims: more ATP, better recovery, fat loss, nervous system balance, strength gains… all from the same “red light” buzzword. In this 3-paper masterclass, Dr. Mike Belkowski breaks the hype down into evidence, endpoints, and bottlenecks. You’ll get a clean, practical analysis of three very different PBM applications: Body circumference reduction (systematic review of sham-controlled RCTs) Autonomic nervous system regulation using HRV after infra-auricular/vagus-region PBM (randomized controlled trial) Upper-body performance on a real-world compound lift (bench press) in collegiate athletes (double-blind repeated-measures) Then we connect the dots: why PBM can show a strong signal in one domain, a weak signal in another, and no signal at all when the limiting factor isn’t mitochondrial energy; but coordination, sleep, stress, or recovery terrain. Bottom line: light is real, but its application is not universal — it works when the tool matches the job. (Educational content only, not medical advice.) - Articles Discussed in Episode: The influence of photobiomodulation on upper body muscular performance in collegiate athletes Effects of Acute Photobiomodulation on Heart Rate Variability in Physically Active Individuals: A Randomized and Controlled Clinical Trial Low-level laser therapy for reducing body circumferences: a systematic review - Key Quotes From Dr. Mike: “The PBM trap is thinking ‘more ATP’ automatically means better everything.” “Light therapy is real, but real does not mean universal. It means context-dependent.” “HRV is a moving target — sleep, caffeine, hydration, stress can drown out small effects.” “If you want nervous system balance, the big levers are still sleep, rhythm, breath, and training load.” “Ask better questions: what tissue, what depth, what dose, what endpoint?” - Key points PBM is a signal, not a guarantee → Match the tool to the job. Paper 1 (LLLT body contouring): short-term circumference reductions beat sham; high satisfaction; good tolerability; only 3 RCTs → promising but early. Devices/wavelengths varied (e.g., 532 nm, 635 nm, 635–680 nm) → can’t yet define “best protocol.” Follow-up windows were short (weeks) → durability still unknown long-term. Mechanism proposed: adipocyte emptying/pores (adipocytolysis / lipid peroxidation) more than guaranteed fat-cell death → lifestyle may determine persistence. Paper 2 (HRV/vagus-region PBM): acute 660 nm infraauricular PBM showed minimal HRV changes in healthy active adults; one entropy metric differed. HRV is a noisy systems output influenced by many variables; acute PBM may be underdosed or target too indirect. Paper 3 (bench press): PBM did not beat sham for 1RM, volume load, or soreness; baseline-to-week improvement likely learning/familiarization, not light. As movement complexity increases, PBM’s effect may drop if the limiter is coordination/neural drive, not local muscle energetics. Core takeaway: PBM efficacy is bottleneck-dependent—hit the bottleneck, see signal; miss it, see nothing. - Episode timeline 0:02–1:58 Setup: PBM isn’t magic—3 papers, 3 targets, 3 outcomes 1:59–14:48 Paper 1: LLLT body circumference systematic review (signal + limits) 15:19–21:47 Paper 2: Vagus-region PBM + HRV trial (mostly null; why that matters) 22:15–28:57 Paper 3: Bench press performance trial (PBM vs sham; no advantage) 29:01–35:19 Compare/contrast: endpoints, bottlenecks, evidence strength, mechanism chain length 35:38–37:23 Practical decision framework by goal (contouring vs HRV vs compound strength) 37:31–39:55 Final thesis: PBM works sometimes — context, dose, and bottleneck decide - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    41 min

  3. 2D AGO

    AI vs The Biological Clock: Mitochondria, Oxidative Stress & Telomeres

    Reproductive aging isn’t just your birthday — it’s biology. In this Deep Dive, Dr. Mike Belkowski breaks down the emerging science of AI in fertility assessment and why the next wave of reproductive medicine will move beyond single-marker thinking (AMH, FSH, AFC, semen analysis) into a multi-dimensional model built on three interconnected pillars: mitochondrial function, oxidative stress, and telomere biology. You’ll learn why egg and sperm quality decline is fundamentally an energy and redox story, why the most meaningful biomarkers are often hard to use clinically (invasive, destructive, non-standardized), and how AI can realistically change the game through imaging, pattern recognition, and multi-omics integration — without replacing clinicians. We also cover the real-world constraints: data quality, bias, explainability, validation, regulation, and privacy; because the future isn’t hype, it’s precision. (Educational content only, not medical advice.) - Article Discussed in Episode: Artificial Intelligence in Assessing Reproductive Aging: Role of Mitochondria, Oxidative Stress, and Telomere Biology - Key Quotes From Dr. Mike: “Fertility decline happens at the level of energy, oxidative stress, and cellular timekeeping.” “Oocytes are an ATP-intensive cell type; energy is the limiting factor.” “ROS isn’t the villain—uncontrolled ROS is the villain.” “Mitochondria, oxidative stress, and telomeres aren’t separate — they amplify each other.” “AI won’t replace clinicians—it can integrate complexity humans can’t.” “The next frontier is multi-layer prediction: hormones + imaging + mitochondrial competence.” - Key points Reproductive aging is biological, not just chronological. The “big 3” drivers: mitochondrial dysfunction + oxidative stress + telomere dynamics. Standard markers (AMH/FSH/AFC; semen analysis) don’t fully predict gamete quality/outcomes. Oocytes are mitochondria-dense; ATP is required for spindle formation, segregation, fertilization, early development. Sperm rely on mitochondria for motility, capacitation, DNA integrity. Mitochondrial biomarkers: mtDNA copy number, membrane potential, ATP, ROS—but many tests are invasive/destructive. ROS is necessary at physiologic levels; excess ROS drives DNA/lipid/protein damage and reproductive decline. Telomeres: shorter telomeres correlate with worse female outcomes; male telomere dynamics differ, but oxidative stress still harms telomeres/DNA. These pillars amplify each other: mito dysfunction → ROS ↑ → telomere damage ↑ → cellular aging ↑. AI’s current traction: embryo grading, IVF outcome prediction, computer-vision sperm analysis. Next frontier: AI integrating hormones + imaging + mitochondrial/oxidative/telomere biomarkers + lifestyle/exposures. Adoption requires explainability, multi-center validation, bias control, privacy, and clear accountability. - Episode timeline 0:19–2:29 Why AI is about to reshape fertility assessment + the 3 pillars framework 2:46–5:32 Mitochondria in eggs/sperm + key mito biomarkers + why testing is hard clinically 5:37–7:42 Oxidative stress: why ROS is both necessary and dangerous + biomarkers + standardization issues 7:42–9:33 Telomeres: female vs male dynamics + the amplification loop (mito ↔ ROS ↔ telomeres) 9:43–11:23 Where AI already works: embryo grading, IVF prediction, sperm analysis + what’s next 11:23–12:34 Real-world constraints: explainability, bias, heterogeneity, validation, regulation, privacy 12:37–15:28 The Energy Code takeaway: fertility as “energy age” + personalized levers + responsible precision 15:35–16:15 Tease: what a next-gen AI fertility clinic could look like - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    17 min

  4. 3D AGO

    Scar Reset: Microneedling + Light + Methylene Blue (The Keloid Breakthrough)

    Most people treat scars like an aesthetic afterthought, but hypertrophic scars and keloids are biologically active tissue: itchy, painful, stiff, inflamed, and often stubbornly persistent. In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down a randomized double-blind clinical trial using a synergistic 3-part approach: microneedling + photodynamic therapy + methylene blue as the photosensitizer. We walk through the exact protocol (5 weekly sessions), how results were measured (JSS + POSAS), and what actually improved — thickness, stiffness, pain, itching, flexibility, pigmentation, vascularity, and patient satisfaction. We also discuss why controlled ROS under photodynamic therapy is different from chronic oxidative stress, why keloids may respond better to 1% methylene blue, and what “resetting the remodeling environment” really means. (Educational content only, not medical advice.) - Article Discussed in Episode: Redefining scar quality: A synergistic approach with micro-needling and photodynamic therapy using methylene blue as a photosensitizer: a randomized clinical trial - Key Quotes From Dr. Mike: “Scars aren’t just leftover tissue... they’re often biologically active.” “Microneedling opens the pathway. Light delivers the signal. Methylene blue is the photochemical tool.” “ROS (reactive oxygen species) isn’t ‘bad’— chronic ROS is bad. Controlled ROS can be therapeutic.” “If you want to change tissue outcomes, you often have to change the tissue environment.” “Methylene blue isn’t just a ‘mitochondria molecule'. In the right context, it’s a precision photochemical lever.” - Key points   Scars are biology, not just cosmetics; keloids/hypertrophic scars can stay inflamed and symptomatic. Trial design: randomized double-blind; 37 patients / 94 scars; 5 sessions, weekly. 4 groups: keloid vs hypertrophic × 0.1% vs 1% methylene blue. Protocol: microneedling (≈1–3 mm) → apply MB → occlude 30 min → light 15 min. Measured with JSS + POSAS (clinician + patient symptoms). Severity drop: JSS score fell roughly 14.69 → 4.69 by 6 months. POSAS: ~50% improvement after treatment; stable through 6 months. Biggest symptom wins: stiffness ↓ ~71%, itching ↓ ~70%, pain ↓ ~69%. 1% MB tended to outperform 0.1% for keloids (stronger photosensitizing effect/penetration). Low adverse events; keloid recurrence ~2% at 6 months; none reported for hypertrophic scars in that window. Mechanism logic: microneedling “restarts remodeling” + MB-PDT generates targeted ROS to modulate fibroblasts/collagen/inflammation. Limitations: small sample, no untreated control, subjective scales, limited objective imaging, follow-up only 6 months. - Episode timeline 0:19–1:31 Why scars are biology + the 3-part stack (microneedling + PDT + methylene blue) 1:36–2:17 Hypertrophic vs keloid + why standard care struggles (recurrence/side effects) 2:20–4:25 Trial setup: 37 patients / 94 scars, 4 groups, 5 weekly sessions + parameters 4:25–5:03 Outcomes measured: JSS + POSAS (clinician + patient symptoms) 5:05–6:13 Results: big drops in severity + symptom relief (stiffness/itching/pain) 6:13–7:37 Dose logic: 1% vs 0.1% MB + “controlled ROS” explanation 7:44–9:48 Mechanism: fibroblasts/collagen remodeling + why the combo is synergistic 9:51–10:48 Safety + recurrence + limitations (and what future trials need) 11:00–14:18 BioLight philosophy: stacking inputs, changing the environment, next steps - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    15 min

  5. MAR 5

    Biohacking Isn’t a Stack — It’s a Science: The Mitochondria-First Framework That Cuts Through the Noise

    This episode is a graduate-seminar style scholarly review of biohacking; not as a vibe or a shopping list, but as an ecosystem of claims, evidence types, incentives, and failure modes. Dr. Mike Belkowski walks through peer-reviewed biochemical arguments, academic frameworks, consumer books, surveys, mainstream media translation, and manifesto-style writing — then filters it all through one lens: mitochondria, redox balance, inflammation control, cellular cleanup, and the upstream metabolic terrain that determines whether “hacks” create resilience or just add noise. You’ll learn why changing 12 variables at once isn’t a protocol (it’s a story), why wearables are dashboards (not engines), how constraints like sleep and circadian rhythm govern everything downstream, and how to use evidence-tiering to separate real effects from compelling narratives. The end result is a practical, mitochondria-first framework: define outcomes, stabilize the baseline, add one lever at a time, and let measurement be the referee... not your identity. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: ​“Biohacking is not one discipline, it’s an ecosystem.” “You can feel like you’re doing a lot while actually destabilizing your physiology.” “People change too many variables too quickly — they never stabilize long enough to see what’s helping.” “The stress of tracking becomes a biological stressor.” “A real biohack improves the slope of recovery and the durability of function.” - Key points Biohacking is an ecosystem, not a single discipline; it contains truth, hype, and ideology. The scholarly move: classify claims by mechanism, evidence type, and limits. Real “biohacking” = shifting upstream terrain (metabolic state), not adding tricks. City analogy: fix the power grid (mitochondria/redox/inflammation) before buying “better cars” (more tools). Maximalist stacks (12 changes at once) create stories, not causal protocols. Health is constrained by fundamentals: sleep, circadian rhythm, movement, nutrients, stress load. Wearables are dashboards: they inform iteration, but don’t change the engine by themselves. Surveys show adoption truth: protocols must be sustainable (time/cost barriers matter). Media rewards novelty → often overemphasizes shortcuts and underemphasizes constraints. Manifesto writing can weaponize mitochondrial language into overconfident worldviews. Common failure modes: novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness. Use evidence tiers to guide safety and precision (don’t treat anecdotes like RCTs). Build a stack like a scientist: one goal, few metrics, one variable at a time. A “real stack” is earned through validated iteration, not purchased. - Episode timeline 0:02–1:31 — Setup: “scholarly review” of biohacking through a mitochondria-first lens; sources overview 1:31–4:57 — Biohacking = ecosystem; classification; metabolic terrain + “city/grid” analogy 4:57–8:15 — Maximalist stack critique; constraints; dashboards vs engines; measurement vs entertainment 8:15–10:52 — Consumer books + surveys + media framing: adoption, hype incentives, sustainability 10:52–12:57 — Manifesto layer: how mitochondria language can out-run evidence 12:57–14:49 — Failure modes (novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness) 14:49–19:47 — Evidence-tiering + what “effectiveness” really means (subjective → functional → biomarkers → long-term) 19:47–23:04 — Practical method: define outcome, simplify metrics, fix terrain, add one lever, evaluate humbly, build stack 23:04–26:59 — Personas + closing thesis: biohacking works when it respects biology, evidence, dose, context, and constraints - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    28 min

  6. MAR 4

    The “Second Hit” After Concussion: How Methylene Blue May Protect the Brain’s Mitochondria

    Traumatic brain injury isn’t just the impact, it’s the secondary injury cascade that follows: swelling, inflammation, oxidative overload, mitochondrial dysfunction, and immune activation that won’t shut off. In this Deep Dive, Dr. Mike Belkowski unpacks a mouse-model study where methylene blue was associated with better outcomes across multiple layers of that cascade: reduced early brain edema, improved acute neurological scores, smaller lesion volume over time, and greater neuronal survival. Then we go deeper into the “Energy Code” mechanisms: microglial activation (the brain’s immune cleanup crew that can become chronically destructive), autophagy (cellular cleanup that clears damaged parts after trauma), and why damaged mitochondria can lock the brain into an inflammation ↔ mitochondrial damage loop. The big message: brain injury is an energy crisis, and strategies that stabilize mitochondrial function, support cleanup, and improve resolution may shift the recovery trajectory. (Educational content only, not medical advice.) - Article Discussed in Episode: Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation - Key Quotes From Dr. Mike: “Pressure inside the skull is like trying to run a high-performance engine while someone steps on the fuel line.” “If microglia stay activated too long, they can become the thing that keeps the injury going.” “Damaged mitochondria drive inflammation. Inflammation drives more mitochondrial damage.” “This is why a mitochondrial-first model of brain resilience makes sense.” “The goal isn’t to eliminate ROS—the goal is to prevent chronic overload and restore redox balance.” - Key points TBI damage expands through secondary injury (swelling, inflammation, oxidative stress, mitochondrial failure, BBB disruption). Swelling = pressure, pressure compromises blood flow/oxygen → brain energy crisis. In a mouse TBI model, methylene blue was associated with: Less edema ~24h Better neuro scores at 24h and 72h Smaller lesion volume at 24h, 72h, and 14d More neuronal survival early Microglia: essential responders, but chronic activation becomes collateral damage. Methylene blue was associated with reduced microglial activation at 72h and 14d. Autophagy = cellular maintenance; after injury, cleanup becomes survival. Study showed markers consistent with higher autophagy activity acutely with methylene blue. Damaged mitochondria amplify inflammation; inflammation further damages mitochondria → self-perpetuating loop. “Mitochondria-first” recovery lens: improve energy efficiency, reduce oxidative overload, support resolution. Stack mindset: light (PBM), sleep/circadian timing, nutrient status shape recovery capacity. Antioxidants aren’t “more is better”; goal is redox balance, not zero ROS. - Episode timeline 0:19–1:42 — Frame: TBI + methylene blue; secondary injury explained 1:42–3:40 — Outcomes: edema ↓, neuro scores ↑, lesion volume ↓, neuronal survival ↑ 3:40–4:59 — Microglia: acute defense vs chronic damage; MB association with reduced activation 4:59–6:20 — Autophagy as cleanup; MB association with increased acute cleanup signaling 6:20–7:40 — Why mitochondria matter: ROS/inflammation loop; MB as mitochondrial efficiency concept 7:40–9:18 — Stack thinking: PBM/light + resolution framing + fundamentals (sleep/circadian/nutrients) 9:18–11:13 — Redox realism + big takeaway: TBI = energy crisis; aging parallels; close - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    12 min

  7. MAR 3

    Alzheimer’s Isn’t Just Plaques — It’s a Mitophagy Breakdown (Brain Energy Failure Explained)

    Alzheimer’s is usually framed as plaques and tangles—but this Deep Dive goes upstream: mitochondrial failure and impaired mitophagy. Dr. Mike Belkowski breaks down mitophagy as the brain’s selective mitochondrial cleanup system—and why neurons are uniquely vulnerable when damaged mitochondria can’t be transported, tagged, and fully degraded. You’ll learn how mitophagy appears impaired across multiple steps in Alzheimer’s (initiation, recruitment, transport, lysosomal fusion, and degradation), how hallmark factors like tau, amyloid-beta, APP fragments (APP-CTFs), and APOE4 can jam the machinery, and why the real therapeutic target may be mitophagy flux—not just turning the process “on,” but ensuring cleanup completes from start to finish. The episode closes with a systems-based framework for breaking the loop: reduce chronic stressors, support mitochondrial signaling, and prioritize lifestyle levers that promote mitochondrial quality control. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches - Key Quotes From Dr. Mike: “Alzheimer’s isn’t just plaques and tangles — it’s also a story about energy failure.” “Mitophagy is selective mitochondrial cleanup.” “If you don’t remove broken mitochondria, they don’t sit quietly—they leak.” “You can’t just ask, ‘Is mitophagy turned on?’ You have to ask, ‘Is mitophagy completing?’” “Damaged mitochondria accumulate → more oxidative stress → more energy failure → worse cleanup.” “The future isn’t just ‘turn on mitophagy.’ It’s support mitophagy flux from start to finish.” - Key points Mitophagy = selective mitochondrial cleanup (tag → wrap → lysosome → recycle). In neurons, cleanup is harder: lysosomes are mainly in the soma, so damaged mitochondria in axons must be transported back. In Alzheimer’s, damaged mitochondria accumulate, especially near synapses → ROS, calcium disruption, inflammation, ATP loss. Evidence summarized: Alzheimer’s brains show reduced mitophagy signatures + structurally damaged mitochondria (cristae disruption, low ATP). Mitophagy impairment can occur at multiple failure points (initiation → LC3 recruitment → AMPK/ULK1/TBK1 signaling → lysosomal fusion). Key principle: initiation ≠ completion; if lysosomal fusion fails, you get “garbage bags with no pickup.” Transport deficits (incl. DISC1-related trafficking roles) can worsen mitochondrial congestion. Alzheimer’s proteins can jam mitophagy: tau (PINK1/Parkin interference), amyloid-beta (context-dependent; flux often blocked downstream). APP-CTFs may correlate strongly with mitophagy marker changes and may disrupt mitochondria-associated membranes (MAMs). APOE4 links to autophagy/lysosomal dysfunction, a major bottleneck for clearance. Therapeutic direction: not just “boost mitophagy,” but support mitophagy flux + lysosomal capacity + brain penetration. Biggest levers aren’t only compounds—exercise, fasting-style metabolic stress, rhythm/sleep are core mitophagy signals; chronic stressors crush it. - Episode timeline 0:19–1:45 — Frame: Alzheimer’s as energy + cleanup failure; define mitophagy 1:45–2:45 — Neuron logistics: soma lysosomes, axonal transport, synaptic vulnerability 2:45–4:20 — Evidence: impaired mitophagy markers + damaged mitochondria; “completion vs initiation” 4:20–5:15 — Transport issues (DISC1) and multi-step failure points 5:15–8:15 — Mapping AD factors to mitophagy failure: tau, amyloid, APP-CTFs/MAMs, APOE4 8:15–9:40 — The vicious loop (mitochondria ↔ ROS ↔ inflammation ↔ clearance failure) 9:40–11:35 — Breaking the loop: flux-first strategy; compounds under investigation; bottlenecks 11:35–14:10 — Lifestyle levers + Biolite “mitochondria stack” framing; systems-based takeaway - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    15 min

  8. MAR 2

    Your Mitochondria Are Listening: The Gut–EV–Mitochondria Axis That Controls Aging, Energy & Fertility

    Mitochondria aren’t isolated “batteries”... they’re sensors responding to your light exposure, diet, sleep, stress, inflammation, toxins, and microbiome. In this Deep Dive, Dr. Mike Belkowski unpacks a powerful emerging framework: the gut–extracellular vesicle–mitochondria axis—how microbial metabolites and tiny biological “delivery packages” (EVs) can travel through the body and influence mitochondrial efficiency, oxidative stress, inflammation, senescence, and tissue resilience. Using reproductive aging as the case study (one of the earliest mirrors of biological age), we zoom out to show why this axis likely impacts systemic aging, brain health, metabolic health, recovery, and longevity. You’ll learn how signals like urolithin A, butyrate, indole compounds, and polyphenol metabolites interact with mitochondrial quality control; and why the real goal isn’t “eliminating ROS,” but restoring redox intelligence and breaking the chronic loops that accelerate aging. (Educational content only, not medical advice.) - Article Discussed in Episode: The Gut–Extracellular Vesicle–Mitochondria Axis in Reproductive Aging: Antioxidant and Anti-Senescence Mechanisms - Key Quotes From Dr. Mike: “If you’re not feeding your microbiome, you’re missing a major upstream lever for mitochondrial health.” “Mitophagy is a clean-up process that helps maintain mitochondrial quality.” “ROS damages mitochondria. Damaged mitochondria produce more ROS.” “Mitochondria aren’t just energy—mitochondria are aging.” “Circadian disruption is a mitochondrial toxin.” - Key points Mitochondria are sensors, not just ATP producers—your inputs are signals. The gut–EV–mitochondria axis: microbiome metabolites + EV cargo influence mitochondrial function system-wide. Reproductive aging is mitochondrial aging: egg/sperm quality depends on energy, membranes, redox, and QC. ROS isn’t “bad”—it’s normal signaling; damage happens when ROS > antioxidant capacity. The microbiome produces metabolites that shape inflammation, redox control, biogenesis, and mitophagy. Urolithin A = mitophagy / mitochondrial housekeeping signal (microbiome-dependent). Butyrate (SCFA) = gut barrier + inflammation modulation + resilience/biogenesis signaling. EVs are delivery packages that can carry enzymes + regulatory signals; cargo quality matters. Chronic stress/inflammation can shift EV cargo toward broadcasting dysfunction. Senescence loop: mitochondrial dysfunction ↔ ROS ↔ inflammation ↔ senescence (self-amplifying). Practical framing: diet, fiber, polyphenols, sleep timing, light, training = information mitochondria respond to. Longevity strategy = break loops and build resilient systems, not symptom-chasing. - Episode timeline 0:19–2:25 — Why mitochondria are sensors; intro to the gut–EV–mitochondria axis 2:25–4:20 — Reproductive aging as a mitochondrial story; ROS as “controlled fire” 4:20–10:18 — Microbiome metabolites: urolithin A, butyrate, indoles, polyphenol metabolites; “diet = information” 10:18–13:46 — What EVs are; protective vs pro-inflammatory cargo; broadcasting dysfunction 13:46–14:34 — Reproductive aging as a window into systemic aging 14:34–19:32 — Biolite “mitochondria stack” lens: light, MB, hydrogen, DDW, circadian rhythm (systems approach) 19:32–21:28 — Antioxidants misconception; restoring redox intelligence vs blunting adaptation 21:28–24:09 — Big synthesis: breaking loops + “your mitochondria are listening” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    24 min
See All (285)

4.8
out of 5
125 Ratings

About

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Information

  • Creator
    Dr. Mike Belkowski
  • Years Active
    2021 - 2026
  • Episodes
    285
  • Rating
    Clean
  • Copyright
    © Copyright 2021 All rights reserved.
  • Show Website
    The Energy Code

You Might Also Like